Evidence map›Paper›PMID 37569836›Full record

ArticleInternational journal of molecular sciences2023

Potential Harm of IQOS Smoke to Rat Liver.

Silvia Granata, Donatella Canistro, Fabio Vivarelli, Camilla Morosini, Laura Rullo, Dario Mercatante, Maria Teresa Rodriguez-Estrada, Alessandra Baracca, Gianluca Sgarbi, Giancarlo Solaini and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Silvia GranataDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, 40126 Bologna, Italy.ORCID 0000-0001-6512-1522
Donatella CanistroDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, 40126 Bologna, Italy.
Fabio VivarelliDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, 40126 Bologna, Italy.ORCID 0000-0002-8734-0985
Camilla MorosiniDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, 40126 Bologna, Italy.ORCID 0000-0002-4022-0900
Laura RulloDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, 40126 Bologna, Italy.ORCID 0000-0002-6146-1690
Dario MercatanteDepartment of Agricultural and Food Sciences, Alma Mater Studiorum, University of Bologna, Viale Giuseppe Fanin, 40-50, 40127 Bologna, Italy.ORCID 0000-0002-8673-2661
Maria Teresa Rodriguez-EstradaDepartment of Agricultural and Food Sciences, Alma Mater Studiorum, University of Bologna, Viale Giuseppe Fanin, 40-50, 40127 Bologna, Italy.ORCID 0000-0001-6406-4183
Alessandra BaraccaLaboratory of Biochemistry and Mitochondrial Pathophysiology, Department of Biomedical and Neuromotor Sciences, University of Bologna, Via Irnerio, 48, 40126 Bologna, Italy.ORCID 0000-0002-0490-1776
Gianluca SgarbiLaboratory of Biochemistry and Mitochondrial Pathophysiology, Department of Biomedical and Neuromotor Sciences, University of Bologna, Via Irnerio, 48, 40126 Bologna, Italy.ORCID 0000-0003-0799-2463
Giancarlo SolainiLaboratory of Biochemistry and Mitochondrial Pathophysiology, Department of Biomedical and Neuromotor Sciences, University of Bologna, Via Irnerio, 48, 40126 Bologna, Italy.ORCID 0000-0001-7825-0446
Severino GhiniDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, 40126 Bologna, Italy.
Ivan FagiolinoGruppo CSA-S.p.A., Via al Torrente 22, 47923 Rimini, Italy.
Stefano SangiorgiDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, 40126 Bologna, Italy.ORCID 0000-0002-3389-283X
Moreno PaoliniDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, 40126 Bologna, Italy.
University of Bologna · ITUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Food and Drug Administration has recently classified the IQOS electronic cigarette as a modified-risk tobacco product. However, IQOS cigarettes still release various harmful constituents typical of conventional cigarettes (CCs), although the concentrations are markedly lower. Here, we investigated the damaging effects of IQOS smoking on the liver. Male Sprague Dawley rats were exposed, whole body, 5 days/week for 4 weeks to IQOS smoke (4 sticks/day), and hepatic xenobiotic metabolism, redox homeostasis and lipidomic profile were investigated. IQOS boosted reactive radicals and generated oxidative stress. Exposure decreased cellular reserves of total glutathione (GSH) but not GSH-dependent antioxidant enzymes. Catalase and xanthine oxidase were greater in the exposed group, as were various hepatic CYP-dependent monooxygenases (CYP2B1/2, CYP1A1, CYP2A1, CYP2E1-linked). Respiratory chain activity was unaltered, while the number of liver mitochondria was increased. IQOS exposure had an impact on the hepatic lipid profile. With regard to the expression of some MAP kinases commonly activated by CC smoking, IQOS increased the p-p38/p38 ratio, while erythroid nuclear transcription factor 2 (Nrf2) was negatively affected. Our data suggest that IQOS significantly impairs liver function, supporting the precautionary stance taken by the WHO toward the use of these devices, especially by young people and pregnant women.

Indexed as

Electronic Nicotine Delivery SystemsTobacco ProductsAnimalsFemaleHumansLiverMalePregnancyRatsRats, Sprague-DawleySmokeSmokedrug metabolismhealth riskheated-tobacco productsliver diseaseoxidative stress

Identifiers

PMID37569836
PMCPMC10419033
OpenAlexW4385606456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.